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The classical pattern of invasive lobular carcinoma (ILC) has become well
established since the tumour was first designated in the 1940's. It is a distinct
histological type of breast cancer, yet the incidence rates accumulated from the
literature are widely divergent and vary from 0.7-20 per cent,' suggesting the
criteria for diagnosis are not well defined. Martinez and Azzopardil in the only
series reported from the United Kingdom studied in detail the histological criteria
for diagnosis and discussed and illustrated the recently described rarer variants.
This study, and the problems of management posed by lobular carcinoma, en-
couraged us to review a censecutive series of invasive breast carcinomas from our
records presenting during 1979. The incidence of ILC, with and without the in situ
lesion, was assessed, the rarer variants of the tumour were sought and some of the
problems presented by this diagnosis considered.
MATERIALS AND METHODS
The material studied comprised 298 consecutive invasive carcinomas of the
female breast in a Caucasian,,population presenting during the year 1979. Five
carcinomas diagnosed on needle biopsy and without a subsequent mastectomy
specimen were excluded on the basis of inadequate tissue for classification. This
left 293 invasive carcinomas in the series diagnosed on either a local excision
(lumpectomy) or a.mastectomy specimen. Lumpectomyspecimenswereadequately
sampled for diagnosis (average 5.2 blocks per case). They were retained in the
series, as their exclusion would have removed patients in the eighth and ninth
decades of life, often preferentially treated by local exision of the tumour.
In the carcinomas reviewed the classical pattern of ILC was easily recognised.
and separated from invasive duct carcinoma (IDC). Its incidence along with the
co-existing in situ lesion was assessed, and the variants summarised and illus-
trated by Martinez and Azzopardi1 were sought.
RESULTS
The review of 293 invasive breast carcinomas identified 34 lobular carcinomas
(11.6 per cent), 254 duct carcinomas (86.7 per cent) and five carcinomas which
could not be classified (1.7 per cent). The duct carcinomas were not further
separated.
In four of the lobular carcinomas, variant pattern dominated; two tumours
had a solid pattern with sheets of confluent uniform cells and sparse hyal.inised
stroma and two were tubulolobular in pattern with small open and solid tubules
105in a targetoid arrangement. Variant patterns more limited in extent were not
unusual in the 30 invasive lobular carcinomas with classical histology. They
included two tumours with small foci of closed and open tubules, two tumours
with an alveolar arrangement, one tumour with signet-ring cell carcinoma and
one tumour with a solid area containing ill-defined clumps of cells. These
variations in pattern did not create any diagnostic difficulties, but their recognition
is relatively recent.
The in situ lesion of lobular carcinoma involving either lobules or ducts or
both was associated with 33 of all carcinomas examined (11.4 per cent). Lobular
carcinoma in situ (LCIS) occurred in 28 of the 34 lobular carcinomas (79.1 per
cent) and in six of the 254 duct carcinomas (2.4 per cent). In the four lobular
carcinomas dominated by variant patterns, in situ lesions were present in one of
the solid and two of the tubulolobular carcinomas.
Lymph nodes were available from 17 cases of ILC. In eight cases the lymph
nodes contained metastases which maintained a small dissociated cell pattern
without sclerosis or structure formation. A tubuloobular carcinoma with lymph
node metastases had the same histology as classical ILC.
DISCUSSION
Classical ILC has distinctive morphology with a small cell infiltrating pattern in
a targetoid arrangement around uninvolved ducts. Associated LCIS involving
lobules or ducts or both may occur with all types of invasive breast carcinoma,
but its predominant association with ILC is a useful indication of type.
In this series 11.6 per cent of the invasive breast carcinomas were infiltrating
lobular in type, and LCIS co-existed in 79.1 per cent of the tumours. The in situ
lesion was not confined to lobular carcinoma and 2.4 per cent of the infiltrating
duct carcinomas had concurrent LCIS. While the incidence of ILC is lower than
the 14.7 per cent found in the other comparable United Kingdom series,' the
concurrent incidence of LCIS is almost identical and supports the validity of the
diagnosis.2
The divergent incident rates of ILC reported from comparable recent series
mainly originating in the USA' are unlikely to be due to racial or geographic
differences, and the lack of established criteria for diagnosis and failure to
recognise the recently described variants are more important factors. With the
now better definition of the histological spectrum of ILC incident rates should
become more uniform.
Four variant forms of ILC occurred, two dominated by the solid pattern of
Fechner3 and two by the tubulolobular carcinoma described by Fisher and
associates.' Co-existing LCIS in the tubulolobular carcinomas and in one of the
solid tumours was a useful aid in diagnosis. It is unlikely these variants would
have been recognised and included in series of infiltrating lobular carcinomas
prior to these reports. While ILC dominated by solid and tubulolobular patterns
is rare it is not unusual for some minor variation in pattern to occur in association
106with the classical histology. If as has recently been suggested 3, 4 variant patterns
represent differentiation in ILC and possibily a better prognosis their recognition
may be useful.
Cases of ILC present over a wide age range, but an unusuallyhighpredominance
of patients was found in the later decades (Table) and also a high mean age of
61 years. This is almost ten years older than the mean age 52.6 years of several
Age <40 40-49 50-59 60-69 70-79 >80
Number of
patients 0 6 9 10 7 2
Table - Age range of 34 patients with invasive lobular carcinoma of the breast.
series taken together,2 but the tumours in the older age range continue to have
concomitant LCIS. The two patients in the ninth decade both had LCIS accom-
panying the invasive lobular carcinoma and extension of the malignancy into
this decade has previously been reported.5
The identification of an invasive breast carcinoma as lobular in type has some
practical importance in predicting the response of metastatic disease to endocrine
manipulation. A high proportion (85-90 per cent) 6, 7 of infiltrating lobular
carcinomas are oestrogen receptor positive, and in the absence of tissue assay
the histological type of the tumour provides strong presumptive evidence of a
positive status which relates to regression with endocrine therapy.
The bilaterality of ILC and its preceding lesion, LCIS, is well recognised, and
26-30 per cent of infiltrating lobular carcinomas are associated with subsequent
invasive carcinoma, usually lobular in type, in the contralateral breast. 8 9 More
recently, a report describes 30 cases of ILC with a 16.6 per cent incidence of
,ubsequent invasive carcinoma in the opposite breast in a minimum follow-up of
four years.1 Since 11.6 per cent of invasive carcinomas in this series are lobular
in type, the diagnosis poses a considerable problem if supervision is to detect a
possible contralateral carcinoma at its earliest stage and before metastases have
occurred and thus ensure the lowest possible mortality. This problem of clinical
management is greatly magnified if the whole spectrum of lobular carcinoma is
considered. The in situ lesion which does not by itself produce a tumour nodulelO
is being increasingly recognised on histological examination as an incidental
finding in breast tissue usually excited for fibrocystic disease (diffuse fibroadenosis).
It identifies a further group of patients having a future risk of invasive breast
carcinoma seven to 12 times greater than a normal population of women.11 Since
the risk is known to be equal in both breasts ipsilateral mastectomy. the usual
treatment prior to 1975, is no longer acceptable and a conservative policy of
management is replacing surgery.
The diagnosis, therefore, of ILC and/or its preceding in situ lesion indicates
a potential bilateral breast malignancy extending over a wide age span, which
creates a formidable problem of follow-up both for the clinician in charge and the
patient, to detect subsequent invasive cancer at its earliest possible stage.
107SUMMARY
Thirty-four invasive lobular carcinomas, including four tumours with variant
patterns, were found in a review of 293 consecutive invasive breast carcinomas,
an incidence of 11.6 per cent. The in situ lesion was associated with 79 per cent
of the tumours. The recognition of this type of breast carcinoma, with its long-
term bilateral risk, poses considerable problems in follow-up, both for theclinician
and the patient.
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